Verily Life Sciences LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Verily Life Sciences LLC
CIK #0001848282
CIK Period
0001848282
Sector Form 13F Holdings Value ($B)
New Providence Acquisition Corp 0.4
DMY Technology Group Inc IV 0.4
ARM Holdings PLC /UK 0.3
Revolution Medicines Inc 0.2
Freshworks Inc 0.2
Tempus AI Inc 0.1
Gitlab Inc 0.1
Uipath Inc 0.1
Prime Medicine Inc 0.1
Dexcom Inc 0.1
MAZE Therapeutics Inc 0.1
Helix Acquisition Corp II 0.0
Figma Inc 0.0
Monte Rosa Therapeutics Inc 0.0
SANA Biotechnology Inc 0.0
Oscar Health Inc 0.0
Magenta Therapeutics Inc 0.0
Relay Therapeutics Inc 0.0
Beam Therapeutics Inc 0.0
Vera Therapeutics Inc 0.0
Lyell Immunopharma Inc 0.0
Foghorn Therapeutics Inc 0.0
CM Life Sciences Inc 0.0
Taysha Gene Therapies Inc 0.0
TScan Therapeutics Inc 0.0
Vaccitech PLC 0.0
Spero Therapeutics Inc 0.0
Tenaya Therapeutics Inc 0.0
HealthCor Catalio Acquisition Corp 0.0
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
13F-NT [0001848282]
3 [0001848282]
4 [0001848282]
D [0001848282]
Form 3/4/5 Subject 2011 - 2026
CapitalG LP
Verily Life Sciences LLC
Alphabet Holdings LLC
Alphabet Inc
GV 2014 LP
Oscar Health Inc
CapitalG 2015 GP LLC
CapitalG GP LLC
GV 2014 GP LLC
CapitalG 2015 LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Oscar Health Inc OSCR
Class A Common Stock
2023-08-17 Sell 525,470 $8.08 4,245,798
Oscar Health Inc OSCR
Class A Common Stock
2023-08-17 Sell 5,719,438 $8.08 46,213,059
Oscar Health Inc OSCR
Class A Common Stock
2023-08-17 Sell 255,092 $8.08 2,061,143
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com